Europe’s first stem cell therapy backed by NICE – PharmaTimes
|
Europe’s first stem cell therapy backed by NICE
PharmaTimes Eisai’s Holoclar, the first stem–cell therapy to be cleared by European regulators, has received a green light for use on the NHS in England and Wales to treat a rare sight condition. The National Institute for Health and Care Excellence has now … |
|
First FDA-approved stem cell trial for shoulder injuries reaches full enrollment
News-Medical.net The trial is the first in the United States to offer an FDA-approved adipose-derived stem cell trial for shoulder injuries. The trial opened in Fargo, North Dakota, and Sioux Falls in December 2016. In this trial, one’s own adipose stem cells are used … |
|
First FDA-approved stem cell trial for shoulder injuries reaches full enrollment
News-Medical.net The trial is the first in the United States to offer an FDA-approved adipose-derived stem cell trial for shoulder injuries. The trial opened in Fargo, North Dakota, and Sioux Falls in December 2016. In this trial, one’s own adipose stem cells are used … |
|
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma.
UroToday The standard of care for most patients with non-muscle-invasive bladder cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Guérin (BCG), which activates the immune system to recognize and destroy malignant cells and has demonstrated … |
Fruitnet |
Stem cell research could double avo production
Fruitnet Researchers at the University of Queensland (UQ) have developed a stem cell multiplication method that could double the state’s avocado production. The growing method could lead to 500 times more avocado plants being supplied to the industry, and could … |